Where do Xenon Pharmaceuticals's ratios come from?

Every ratio is computed from Xenon Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-4,974.3%—	——	——	-1,368.9%-940pp
Net margin	-4,612.1%—	——	——	-1,328.9%-901pp
Returns
Return on equity	-51.8%-23.9pp	-27.8%-5.7pp	-22.1%-2.4pp	-19.7%+2.1pp
Return on invested capital	-73.7%-34.2pp	-39.6%-10.4pp	-29.2%-4.8pp	-24.4%+6.4pp
Efficiency
Asset turnover	0×—	0×—	0×0.0×	0×0.0×
Liquidity
Current ratio	13.4×-4.4×	17.8×-5.8×	23.6×-2.8×	26.4×-12.6×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$7.34-24.3%	$9.69-30.1%	$13.87+16.4%	$11.92-5.5%
Valuation
Market capitalization	$3.46B+15.9%	$2.99B-7.3%	$3.22B+30.7%	$2.47B+53.0%
Price / sales	461.8×—	——	——	261.4×+174×
Price / book	6×+2.0×	4×+0.5×	3.5×+0.1×	3.4×+0.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Xenon Pharmaceuticals's ratios come from?: Every ratio is computed from Xenon Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.